Australians with ADHD could soon save even more money, thanks to a commitment from both the Labor and Coalition parties to reduce the cost of medications listed on the Pharmaceutical Benefits Scheme (PBS).
ADHD Australia CEO, Melissa Webster, says the reduction in costs will help so many who are already struggling with the current cost of living. “This is a big step in the right direction for families around Australia who have already paid hundreds of dollars just to get a diagnosis.”
The Australian Government subsidises the costs of medicines that are listed on the PBS. This includes certain ADHD medication, however eligibility can depend on age, when the diagnosis occurred and the specific medication.
The current cost for a patient with a prescription of a PBS-listed medication is $31.60. This cost would be reduced to $25 if Labor or the Coalition wins the upcoming election.
Dr Ashar Khan, Senior Psychiatrist and ADHD Australia Board Member said that eligibility of access to PBS-listed medication should also be expanded. “Adults who were not diagnosed during childhood or adolescence do not currently have access to some PBS-listed ADHD medications. Living with ADHD causes significant economic burden. Expanding equitable access for PBS subsidies for all ADHD medications would minimise future risk of ADHD-related medical issues and provide positive outcomes for their quality of life.”
With the Federal Election called for 3 May 2025, ADHD Australia calls on all parties to commit to the full suite of reforms recommended by the Senate Inquiry into Assessment and Support Services for people with ADHD, including better access to diagnosis, support in schools, and workplace protections.
Contact: media@adhdaustralia.org.au
